Syneos Health Investor Relations Material
Latest events
Q4 2022
Syneos Health
Q2 2023
9 Aug, 2023
Q1 2023
10 May, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Syneos Health Inc
Access all reports
Syneos Health Inc is a contract research and commercialization organization serving the biopharmaceutical industry. The company provides clinical development, regulatory consulting, and commercialization solutions from early-phase trials through post-approval support. It partners with clients globally to bring therapies to market. The company is headquartered in Morrisville, North Carolina, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
SYNH
Country
🇺🇸 United States